Alternative Targets to Fight Alzheimer's Disease: Focus on Astrocytes
ReviewHumansOther animals
- Design
- Review
- Subjects
- Not stated in the abstract
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- What could work against Alzheimer's disease by targeting astrocytes: a review of mechanisms and the last five years of research, including palmitoylethanolamide as a possible disease-modifying approach.
What the authors reported
Palmitoylethanolamide can modulate astrocytes according to their morphological and functional state, the authors say, and they suggest this as a possible disease-modifying approach worth exploring. No study-level results or numbers are given in the abstract.
Limits of this study
A narrative review with no numbers. One author discloses a previous (2019 to 2020) work contract with Epitech Group, which makes ultramicronised PEA.
Source
PubMed 33921556 · doi:10.3390/biom11040600
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.